Analyst firms · Jefferies · FMS
Jefferies FMS price target and rating history
Fresenius Medical Care AG (FMS) · Health Care
Jefferies rates Fresenius Medical Care AG (FMS) Underperform with a $11.70 price target, as of its latest action on Jan 3, 2023. It has published 5 rating actions on FMS since November 2021, including 2 upgrades and 3 downgrades.
- Current rating
- Underperform
- Price target
- $11.70
- Median target, all firms
- Too few
- Actions on FMS
- 5
Jefferies price target on FMS
Every Jefferies rating on FMS
- Jan 3, 2023
- Oct 10, 2022
- Jun 27, 2022
- Feb 11, 2022
- Nov 11, 2021
How other firms rate FMS
Each firm's latest rating and stated target in the last 12 months.
| Firm | Rating | Price target | Date |
|---|---|---|---|
| Berenberg | Hold | Sep 29, 2026 | |
| BNP Paribas Exane | Underperform | $19.89 | Jul 28, 2026 |
| Bernstein | Mkt Perform | Jul 16, 2026 | |
| Goldman Sachs | Neutral | Jan 20, 2026 |
Questions about Jefferies and FMS
- What is Jefferies's price target for FMS?
- Jefferies's latest stated price target for Fresenius Medical Care AG (FMS) is $11.70, from its action on Jan 3, 2023.
- What is Jefferies's rating on FMS?
- Jefferies rates FMS Underperform, a bearish rating, as of Jan 3, 2023.
- When did Jefferies last change its view on FMS?
- On Jan 3, 2023, Jefferies downgrades to Underperform from Buy, price target $14 to $11.70.
All Jefferies ratingsFMS news and filingsEvery analyst firm
From rating actions in the Quantisnow feed. A target holds until the firm states a new one; a reiteration with no target keeps the last one. Not investment advice.